A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment strategies are desperately needed due to limited standard therapies. Activation of the Erk, Akt, and STAT3pathways is implicated in the prognosis of HCC. The Se,Se′-1,4-phenylenebis(1,2-ethanediyl) bisisoselen...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmaceuticals (Basel)
Asıl Yazarlar: Tagaram, Hephzibah Rani S., Desai, Dhimant, Li, Guangfu, Liu, Dai, Rountree, C. Bart, Gowda, Kavitha, Berg, Arthur, Amin, Shantu, Staveley-O’Carroll, Kevin F., Kimchi, Eric T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4932536/
https://ncbi.nlm.nih.gov/pubmed/27023566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph9020018
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller